Literature DB >> 352124

Pharmacokinetics of antiarrhythmic drugs.

R L Woosley, D G Shand.   

Abstract

A knowledge of the determinants of the plasma concentrations of antiarrhythmic drugs is important because variation in plasma levels is often greater than the desired therapeutic range. The basic principles of pharmacokinetics are outlined and their application to the design of dosage regimens described. These principles are illustrated in a review of the pharmacokinetics of lidocaine and its congeners, procainamide and its active metabolite (N-acetylprocainamide), quindine, disopyramide, phenytoin and propranolol, with particular emphasis of the factors that contribute to altered disposition.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 352124     DOI: 10.1016/0002-9149(78)90851-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  Pharmacological Therapy of Cardiac Arrhythmias.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-11       Impact factor: 2.300

2.  Renal elimination of amiodarone and its desethyl metabolite.

Authors:  L Harris; C R Hind; W J McKenna; C Savage; S J Krikler; G C Storey; D W Holt
Journal:  Postgrad Med J       Date:  1983-07       Impact factor: 2.401

3.  Lorcainide infusion in the treatment of ventricular premature beats (VPB).

Authors:  U Klotz; P M Müller-Seydlitz; P Heimburg
Journal:  Eur J Clin Pharmacol       Date:  1979-08       Impact factor: 2.953

Review 4.  Impact of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery: a systematic review of randomized controlled trials.

Authors:  Grace C McCarthy; Sohair A Megalla; Ashraf S Habib
Journal:  Drugs       Date:  2010-06-18       Impact factor: 9.546

5.  Rapid prediction of individual dosage requirements for lignocaine.

Authors:  S Vozeh; M Berger; M Wenk; R Ritz; F Follath
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

6.  Disopyramide pharmacokinetics in patients with acute myocardial infarction.

Authors:  P J Pentikäinen; H Huikuri; A J Jounela; G Wilen
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.